211 related articles for article (PubMed ID: 7513191)
41. Influence of chronic inorganic lead exposure on regional dopamine and 5-hydroxytryptamine turnover in rat brain.
Lasley SM; Greenland RD; Minnema DJ; Michaelson IA
Neurochem Res; 1984 Dec; 9(12):1675-88. PubMed ID: 6085136
[TBL] [Abstract][Full Text] [Related]
42. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
[TBL] [Abstract][Full Text] [Related]
43. Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain.
Preston KL; Wagner GC; Schuster CR; Seiden LS
Brain Res; 1985 Jul; 338(2):243-8. PubMed ID: 2411342
[TBL] [Abstract][Full Text] [Related]
44. Simultaneous measurement of monoamines, their metabolites and 2,3- and 2,5-dihydroxybenzoates by high-performance liquid chromatography with electrochemical detection. Application to rat brain dialysates.
Duine JM; Floch F; Cann-Moisan C; Mialon P; Caroff J
J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):350-3. PubMed ID: 9824250
[TBL] [Abstract][Full Text] [Related]
45. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
Nazarali AJ; Reynolds GP
Cell Mol Neurobiol; 1992 Dec; 12(6):581-7. PubMed ID: 1283363
[TBL] [Abstract][Full Text] [Related]
46. Alteration of the turnover of dopamine and 5-hydroxytryptamine in rat brain associated with hypothermia.
Okuda C; Saito A; Miyazaki M; Kuriyama K
Pharmacol Biochem Behav; 1986 Jan; 24(1):79-83. PubMed ID: 2418447
[TBL] [Abstract][Full Text] [Related]
47. Effect of barbitone sodium and thiopental sodium on brain dopamine, noradrenaline, serotonin and 5-hydroxyindoleacetic acid content in Arvicanthis niloticus.
Fathi MM; Taha HM; Fahim el-S
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 86(1):185-90. PubMed ID: 2435454
[TBL] [Abstract][Full Text] [Related]
48. Circadian rhythms in catecholamine metabolites and cyclic nucleotide production.
Kafka MS; Benedito MA; Roth RH; Steele LK; Wolfe WW; Catravas GN
Chronobiol Int; 1986; 3(2):101-15. PubMed ID: 2824067
[TBL] [Abstract][Full Text] [Related]
49. Human brain levels of monoamines and their metabolites. Postmortem investigations.
Gottfries CG
Acta Psychiatr Scand Suppl; 1980; 280():49-61. PubMed ID: 6157304
[No Abstract] [Full Text] [Related]
50. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Bergeron M; Reader TA; Layrargues GP; Butterworth RF
Neurochem Res; 1989 Sep; 14(9):853-9. PubMed ID: 2480534
[TBL] [Abstract][Full Text] [Related]
51. Ontogeny of brain monoamines in lean and obese female Zucker rats.
Orosco M; Trouvin JH; Cohen Y; Jacquot C
Physiol Behav; 1986; 36(5):853-6. PubMed ID: 2424037
[TBL] [Abstract][Full Text] [Related]
52. Brain norepinephrine reductions in soman-intoxicated rats: association with convulsions and AChE inhibition, time course, and relation to other monoamines.
el-Etri MM; Nickell WT; Ennis M; Skau KA; Shipley MT
Exp Neurol; 1992 Nov; 118(2):153-63. PubMed ID: 1426125
[TBL] [Abstract][Full Text] [Related]
53. Monoamine metabolism in senile dementia of Alzheimer type.
Cross AJ; Crow TJ; Johnson JA; Joseph MH; Perry EK; Perry RH; Blessed G; Tomlinson BE
J Neurol Sci; 1983; 60(3):383-92. PubMed ID: 6195313
[TBL] [Abstract][Full Text] [Related]
54. Cerebrospinal fluid amine metabolites in acute schizophrenia.
Post RM; Fink E; Carpenter WT; Goodwin FK
Arch Gen Psychiatry; 1975 Aug; 32(8):1063-9. PubMed ID: 1156113
[TBL] [Abstract][Full Text] [Related]
55. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
[TBL] [Abstract][Full Text] [Related]
56. Effects of acute administration of cyclazocine on the metabolism of biogenic amines in different regions of rat brain.
Gavend MM; Serre F; Gavend MR; Ragoucy C; Caron P
Psychopharmacology (Berl); 1981; 75(1):79-83. PubMed ID: 6171003
[TBL] [Abstract][Full Text] [Related]
57. Monoamines and monoamine metabolites in brains from demented schizophrenics.
Winblad B; Bucht G; Gottfries CG; Roos BE
Acta Psychiatr Scand; 1979 Jul; 60(1):17-28. PubMed ID: 474174
[TBL] [Abstract][Full Text] [Related]
58. Studies on the central activity of kinins.
Moniuszko-Jakoniuk J; Wiśniewski K
Pol J Pharmacol Pharm; 1976; 28(6):655-9. PubMed ID: 1012986
[TBL] [Abstract][Full Text] [Related]
59. [Effect of fluvoxamine, a new antidepressant drug, on monoamine dynamics in the rat cerebral limbic system and its pharmacological characteristic].
Baba T; Takeda H; Lee JW; Takada K; Shibuya T
Nihon Yakurigaku Zasshi; 1995 Mar; 105(3):177-85. PubMed ID: 7536700
[TBL] [Abstract][Full Text] [Related]
60. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
